MedTrace Logo

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

NCT06727838 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-04-24

No results posted yet for this study

Summary

This study was a single-center, open, fixed-sequence, self-controlled trial design conducted in healthy subjects.

Conditions

Interventions

DRUG

HRS-7535 tablets

HRS-7535 tablets.

DRUG

Metformin Hydrochloride Extended-release Tablets

Metformin Hydrochloride Extended-release Tablets.

DRUG

Metformin Hydrochloride Tablets

Metformin Hydrochloride Tablets.

Sponsors & Collaborators

  • Shandong Suncadia Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2025-01-25
Completion
2025-01-25

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06727838 on ClinicalTrials.gov